Doncasters Raises $919 Million in NYSE IPO as Aerospace Growth Accelerates 
Tesla and NatPower Partner on $5 Billion Battery Storage Expansion in Europe 
SpaceX Stock Rebounds After Sharp Selloff, But Valuation Concerns Persist 
Nike CFO Shake-Up Fuels Concerns Over Turnaround Strategy 
Tencent Reviews Marvelous Stake as Gaming Giant Reassesses Global Investment Strategy 
Ryan Cohen Rejects GameStop Pay Package, Prepares New eBay Acquisition Plan 
Kioxia Targets U.S. Listing as AI Chip Boom Accelerates 
Bain Capital Nears Deal for Majority Stake in Volkswagen Marine Engine Unit Everllence 
Heineken Names JDE Peet’s CEO Rafael Oliveira as New Chief Executive 
Nissan Halts Electric Qashqai Development Amid EV Market Challenges 
Alphabet Replaces Verizon in Dow Jones Industrial Average 
DOJ Opens Investigation Into NYC Coffee Shop Over Anti-Goldman Social Media Post 
Samsung and SK Hynix Shares Jump After Micron Earnings Boost AI Chip Optimism 
SK Hynix Targets $29.4 Billion Nasdaq Listing to Expand AI Chip Business 
WiseTech Global Denies Knowledge of Investigation Into Founder Richard White 
Trump Orders DOJ Investigation Into Exxon, Chevron Over High Gas Prices 
Trip.com Shares Tumble After Q1 Profit Drops and Weak Revenue Growth Outlook 
REDWOOD CITY, Calif., Feb. 24, 2016 -- Cardica, Inc. (Nasdaq:CRDC) today announced that Julian Nikolchev, president and CEO, and Robert Newell, CFO, will participate at the BTIG 2016 MedTech Conference on Thursday, February 25, 2016.
The conference is being held from February 24-26, 2016, at The Cliff Lodge in Snowbird, Utah. The conference format consists of one-on-one meetings and will not be webcast.
About Cardica
Cardica designs and manufactures proprietary stapling and anastomotic devices for cardiac and minimally invasive surgical procedures. Cardica's technology portfolio is intended to reduce operating time and facilitate minimally invasive and robot-assisted surgeries. Cardica’s MicroCutter XCHANGE® 30, that includes a cartridge-based articulating surgical stapling device with a five-millimeter shaft diameter and staples, is manufactured and cleared for use in the United States for transection and resection in multiple open or minimally invasive urologic, thoracic and pediatric surgical procedures, as well as application for transection, resection and/or creation of anastomoses in the small and large intestine and the transection of the appendix. The MicroCutter XCHANGE 30 white cartridge staple has application in vascular tissue. In addition, Cardica manufactures and markets its automated anastomosis systems, the C-Port® Distal Anastomosis Systems and PAS-Port® Proximal Anastomosis System for coronary artery bypass graft (CABG) surgery, and has shipped over 57,500 units throughout the world.
Contact: Bob Newell Vice President, Finance and Chief Financial Officer (650) 331-7133 [email protected]
